Item | Control Group | Treatment Group | Z-value | P-value |
Age (yr) | 54.00 (48.50, 61.50) | 55.00 (47.50, 63.50) | −1.023 | 0.254 |
Percentage of females (%) | 16 (45.7) | 16 (45.7) | N/A* | 1 |
Height (m) | 1.64 (1.57, 1.73) | 1.67 (1.60, 1.71) | −0.218 | 0.828 |
Weight (kg) | 62.98 (56.03, 70.48) | 64.94 (59.46, 72.69) | −1.075 | 0.082 |
BMI (kg/m2) | 22.81 (21.75, 24.30) | 23.17 (21.28, 24.10) | −1.473 | 0.063 |
FPG (mmol/L) | 6.00 (5.65, 6.40) | 6.00 (5.70, 6.30) | −0.483 | 0.629 |
2hPG (mmol/L) | 9.10 (8.40, 9.95) | 9.00 (8.10, 9.70) | −0.882 | 0.378 |
HbA1c (%) | 6.20 (6.10, 6.30) | 6.10 (6.00, 6.30) | −1.400 | 0.162 |
Fins (uU/mL) | 9.53 (8.27, 11.00) | 10.35 (9.23, 12.73) | −1.556 | 0.120 |
HOMA-IR | 2.50 (2.16, 2.87) | 2.76 (2.30, 3.18) | −1.532 | 0.125 |